Evidence map›Paper›PMID 36756102›Full record

ArticleSouth Asian journal of cancer2022

End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?

Anjana Joel, Ashish Singh, Julie Hepzibah, Antony Devasia, Santosh Kumar, Birla Roy Gnanamuthu, Anuradha Chandramohan, Arun Jacob Philip George, Nirmal Thampi John, Bijesh Yadav and 4 more

Abstract read
In one paragraph

Article in South Asian journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anjana JoelDepartment of Medical Oncology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.ORCID 0000-0002-6821-5900
Ashish SinghDepartment of Medical Oncology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Julie HepzibahDepartment of Nuclear Medicine, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Antony DevasiaDepartment of Urology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Santosh KumarDepartment of Urology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Birla Roy GnanamuthuDepartment of Thoracic Surgery, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Anuradha ChandramohanDepartment of Radiology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Arun Jacob Philip GeorgeDepartment of Urology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Nirmal Thampi JohnDepartment of Urology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Bijesh YadavDepartment of Biostatistics, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Ajoy Oommen JohnDepartment of Medical Oncology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Josh Thomas GeorgyDepartment of Medical Oncology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Subhashini JohnDepartment of Radiotherapy, Christian Medical College (CMC), Vellore, Tamil Nadu, India.
Raju Titus ChackoDepartment of Medical Oncology, Christian Medical College (CMC), Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anjana Joel

Indexed as

germ cell tumorPET-CTpost-chemotherapy residual massesseminoma

Identifiers

PMID36756102
PMCPMC9902077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.